Key features and details
- Mouse polyclonal to Calumenin
- Suitable for: WB
- Reacts with: Human
- Isotype: IgG
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Storage bufferpH: 7.20
Constituent: 2.68% PBS
Concentration information loading...
PurityProtein A purified
Our Abpromise guarantee covers the use of ab72571 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/500 - 1/1000. Predicted molecular weight: 37 kDa.|
FunctionInvolved in regulation of vitamin K-dependent carboxylation of multiple amino-terminal glutamate residues. Seems to inhibit gamma-carboxylase GGCX. Binds 7 calcium ions with a low affinity.
Tissue specificityUbiquitously expressed. Expressed at high levels in heart, placenta and skeletal muscle, at lower levels in lung, kidney and pancreas and at very low levels in brain and liver.
Sequence similaritiesBelongs to the CREC family.
Contains 6 EF-hand domains.
Cellular localizationEndoplasmic reticulum lumen. Secreted. Melanosome. Sarcoplasmic reticulum lumen. Identified by mass spectrometry in melanosome fractions from stage I to stage IV.
- Information by UniProt
- CALU antibody
- CALU_HUMAN antibody
- Calumenin 1 antibody
All lanes : Anti-Calumenin antibody (ab72571) at 1/500 dilution
Lane 1 : Calumenin transfected 293T cell lysate
Lane 2 : Non transfected 293T cell lysate
Lysates/proteins at 25 µg per lane.
All lanes : Goat Anti-Mouse IgG (H&L)-HRP Conjugate at 1/2500 dilution
Predicted band size: 37 kDa
Observed band size: 50 kDa why is the actual band size different from the predicted?
ab72571 has been referenced in 2 publications.
- Gharesi-Fard B et al. Alteration in the Expression of Proteins in Unexplained Recurrent Pregnancy Loss Compared with in the Normal Placenta. J Reprod Dev N/A:N/A (2014). WB ; Human . PubMed: 24621454
- Voisin SN et al. Identification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQ. PLoS One 6:e16352 (2011). WB, IHC-P ; Human . PubMed: 21305022